EBIT: Income before interest and taxes.
Pacific Biosciences of California, Inc. (PACB) had EBIT of $-38.88M for the most recently reported fiscal quarter, ending 2025-09-30.
| Income Statement Financials | |
$38.44M |
|
$-38.00M |
|
$22.54M |
|
$15.90M |
|
$77.32M |
|
$-38.88M |
|
$1.26M |
|
$-37.62M |
|
$-37.62M |
|
$-38.00M |
|
$-38.00M |
|
$-38.00M |
|
$-38.00M |
|
|
EBIT |
$-38.88M |
$-35.40M |
|
300.84M |
|
300.84M |
|
$-0.13 |
|
$-0.13 |
|
| Balance Sheet Financials | |
$394.24M |
|
$22.13M |
|
$408.92M |
|
$803.16M |
|
$63.21M |
|
$645.16M |
|
$703.86M |
|
$767.07M |
|
$36.09M |
|
$-297.81M |
|
$36.09M |
|
301.85M |
|
| Cash Flow Statement Financials | |
$-92.14M |
|
$89.42M |
|
$3.43M |
|
$57.59M |
|
$58.30M |
|
$0.71M |
|
$32.08M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
6.24 |
|
-- |
|
-- |
|
0.95 |
|
17.88 |
|
41.36% |
|
-101.13% |
|
-101.13% |
|
-- |
|
-97.86% |
|
-98.85% |
|
$-93.99M |
|
-- |
|
-- |
|
-- |
|
0.05 |
|
0.42 |
|
1.26 |
|
71.68 |
|
-105.29% |
|
12.76% |
|
-4.73% |
|
-5.58% |
|
$0.12 |
|
$-0.31 |
|
$-0.31 |
|